Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Findcure Biosciences divulges new tyrosine-protein kinase receptor UFO inhibitors

Feb. 2, 2022

Sichuan Haisco Pharmaceutical discovers polymerase basic protein 2 inhibitors

Feb. 2, 2022

PI3K-delta inhibitors patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Feb. 2, 2022

New DDR1 and/or DDR2 inhibitors identified at Galapagos

Feb. 2, 2022

Science & Technology Development Fund Authority presents new antiviral nucleosides

Feb. 2, 2022

New murine model of AIH developed using a human liver protein

Feb. 2, 2022

Drug cocktail is step up for leg regeneration

Feb. 1, 2022

Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study

Feb. 1, 2022

Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology

Feb. 1, 2022

Ethris to advance mRNA-based therapeutics for respiratory diseases

Feb. 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...